At least a decade ago IBM developed an early AI application to be used by the M.D. Anderson Medical Group. It was intended to assist oncologists by matching anti-cancer therapeutics. with the appropriate cancers. Their efforts were frustrating, and challenging to all concerned. In a clinical setting the M.D. Anderson oncology doctors terminated the experiment. The data base was inadequate, and physicians did not know how to use it for clinical work. It was inefficient and much time was devoted to learning how it worked. The project was abandoned. It remained an experiment and was not mature enough to begin a formal clinical trial.
The FDA (Food and Drug Administration) uses a well organized methodology of Phase I, II, and III successful testing prior to approval for marketing for clinical use. The routine applies to medical devices as well as pharmaceuticals. Even after approval for marketing the FDA follows closely to monitor for unexpected adverse events.
Advances in Artificial Intelligence in Medicine.
Artificially intelligent computer systems are used extensively in medical sciences. Common applications include diagnosing patients, end-to-end drug discovery and development, improving communication between physician and patient, transcribing medical documents, such as prescriptions, and remotely treating patients.
No comments:
Post a Comment